Mentioned in ?
References in periodicals archive ?
AN army-issue HK11 machine gun and a TV were stolen from a 34-year-old man's home in Valadinou street, Larnaca it emerged on Wednesday.
The markers approved for prevalidation were human kallikrein 2 (hk2), hk4, hk11, thrombospondin 1, percent [-2]proPSA, and EPCA2 (early prostate-specific antigen 2).
We measured hK5, hK6, and hK11 by sandwich-type ELISA, 96-well plates, as described earlier (19-21) with use of biotinylated detection antibodies, alkaline phosphatase-conjugated streptavidin and diflunisal phosphate substrate.
8 cents (Year ended 31 December 2008: Basic earnings pershare of HK11.
In the present study, we monitored the effects of hormone treatment on serum and urine concentrations of hK2, hK3, hK4, hK5, hK6, hK7, hK8, hK10, hK11, hK13, and hK14 in female-to-male transsexuals receiving high-dose testosterone treatment for 4-12 months.
In this study, we examined the effect of hormone treatment on serum and urine concentrations of hK2 to hK8, hK10, hK11, hK13, and hK14, obtained from male-to-female transsexuals who were receiving combined estrogen and antiandrogen therapy.
Seminal plasma samples were pooled and deprived of hK11 by elution from an immunoaffinity column containing immobilized hK11-specific antibody.
She was the first to purify and functionally characterize hK6 and hK10 from ovarian cancer ascites fluid and hK11, a candidate prostate cancer biomarker, from seminal plasma.
Recently, four other members of the human kallikrein family, hK5, hK6 (neurosin), hK10 (normal epithelial cell specific 1), and hK11 (trypsin-like serine protease), were found to be potential serum biomarkers for breast, ovarian, and prostate cancer (10-13).
Recombinant hK1, hK2, hK3, hK4, hK5, hK6, hK7, hK8, hK9, hK10, hK11, hK12, hK14, and hK15 proteins did not produce measurable readings, even at concentrations 1000-fold higher than that of hK13.
Recently, three other members of this family, hK6 (also known as neurosin), hK10 [also known as normal epithelial cell specific 1 (NES1)], and hK11 [also known as trypsin-like serine protease (TLSP)], have been shown to be potential biomarkers for ovarian and prostate cancer (4-6).
More recently, hK11 was also shown to be a potential marker for ovarian and prostate cancer (71).